Corrigendum] Effects of the Tangningtongluo formula as an alternative strategy for diabetics via upregulation of insulin receptor substrate-1
Subsequently to the publication of this article, the authors have realized that Fig. 4 contained some incorrectly incorporated data panels; specifically, the A‑d, B‑b and B‑c panels did not display the correct data. The revised version of Fig. 4 featuring the correct data for the A‑d, B‑b and B‑c panels is shown on the next page. Note that these errors did not affect the overall conclusions reported in the paper. The authors apologize to the Editor of Molecular Medicine Reports and to readership for any inconvenience caused. [the original article was published in Molecular Medicine Reports 16: 703‑709, 2017; DOI: 10.3892/mmr.2017.6679].
Errataetall: |
ErratumFor: Mol Med Rep. 2017 Jul;16(1):703-709. - PMID 28586073 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
---|---|
Enthalten in: |
Molecular medicine reports - 20(2019), 5 vom: 30. Nov., Seite 4391-4392 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cheng, Long [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 28.10.2019 published: Print-Electronic ErratumFor: Mol Med Rep. 2017 Jul;16(1):703-709. - PMID 28586073 Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3892/mmr.2019.10649 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM300947003 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM300947003 | ||
003 | DE-627 | ||
005 | 20231225103616.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3892/mmr.2019.10649 |2 doi | |
028 | 5 | 2 | |a pubmed24n1003.xml |
035 | |a (DE-627)NLM300947003 | ||
035 | |a (NLM)31485640 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cheng, Long |e verfasserin |4 aut | |
245 | 1 | 0 | |a Corrigendum] Effects of the Tangningtongluo formula as an alternative strategy for diabetics via upregulation of insulin receptor substrate-1 |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 28.10.2019 | ||
500 | |a published: Print-Electronic | ||
500 | |a ErratumFor: Mol Med Rep. 2017 Jul;16(1):703-709. - PMID 28586073 | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Subsequently to the publication of this article, the authors have realized that Fig. 4 contained some incorrectly incorporated data panels; specifically, the A‑d, B‑b and B‑c panels did not display the correct data. The revised version of Fig. 4 featuring the correct data for the A‑d, B‑b and B‑c panels is shown on the next page. Note that these errors did not affect the overall conclusions reported in the paper. The authors apologize to the Editor of Molecular Medicine Reports and to readership for any inconvenience caused. [the original article was published in Molecular Medicine Reports 16: 703‑709, 2017; DOI: 10.3892/mmr.2017.6679] | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Published Erratum | |
700 | 1 | |a Song, Junmei |e verfasserin |4 aut | |
700 | 1 | |a Li, Geng |e verfasserin |4 aut | |
700 | 1 | |a Liu, Yue |e verfasserin |4 aut | |
700 | 1 | |a Wang, Yuming |e verfasserin |4 aut | |
700 | 1 | |a Meng, Xiangbao |e verfasserin |4 aut | |
700 | 1 | |a Sun, Guibo |e verfasserin |4 aut | |
700 | 1 | |a Sun, Xiaobo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Molecular medicine reports |d 2008 |g 20(2019), 5 vom: 30. Nov., Seite 4391-4392 |w (DE-627)NLM192195727 |x 1791-3004 |7 nnns |
773 | 1 | 8 | |g volume:20 |g year:2019 |g number:5 |g day:30 |g month:11 |g pages:4391-4392 |
856 | 4 | 0 | |u http://dx.doi.org/10.3892/mmr.2019.10649 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 20 |j 2019 |e 5 |b 30 |c 11 |h 4391-4392 |